A detailed history of National Bank Of Canada transactions in Neogenomics Inc stock. As of the latest transaction made, National Bank Of Canada holds 3,560 shares of NEO stock, worth $58,811. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,560
Previous 3,560 -0.0%
Holding current value
$58,811
Previous $55,000 10.91%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$14.06 - $16.79 $42,180 - $50,370
3,000 Added 535.71%
3,560 $55,000
Q3 2022

Oct 13, 2022

SELL
$7.86 - $12.91 $8,253 - $13,555
-1,050 Reduced 65.22%
560 $5,000
Q2 2022

Jul 28, 2022

SELL
$7.06 - $13.97 $13,696 - $27,101
-1,940 Reduced 54.65%
1,610 $13,000
Q1 2022

May 05, 2022

SELL
$12.15 - $35.28 $1,822 - $5,292
-150 Reduced 4.05%
3,550 $43,000
Q4 2021

Jan 24, 2022

BUY
$30.49 - $48.49 $112,813 - $179,413
3,700 New
3,700 $126,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.08B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.